An advisory I subscribe to just recommended DGX and said;"---Our analysis indicates that acquisitions and organic growth will replace the lost UnitedHealth revenues. We also conclude that DGX is now sellng for below instrinsic value. Making conservative assumptions about revenue growth and profit margins, as well as the company's overall cost of capital,, we conclude that the stock should be selling for at least 5% more than its recent price. We expect DGX to reach our $75 price target within two years."So I bought today @ $52.96. Hey, that will be a 42% gain!!!!